Document Detail


Mortality following nursing home-acquired lower respiratory infection: LRI severity, antibiotic treatment, and water intake.
MedLine Citation:
PMID:  21514897     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: In some nursing home populations, antibiotic treatment may not reduce mortality following lower respiratory infection (LRI). To better inform treatment decisions, we determined influences on mortality following LRI among antibiotic-treated and non-antibiotic-treated residents in 2 populations.
DESIGN: Observational, prospective, cohort studies.
SETTING: Ninety-seven nursing homes (36 US, 61 Netherlands).
PARTICIPANTS: Residents (1044 US, 513 Netherlands) who met a standardized study definition for LRI.
MEASUREMENTS: Demographics, symptoms and physical findings of LRI, functional status, major illness diagnoses, dementia status, treatments, and date of death within 6 months after diagnosis.
METHODS: We estimated a 2-period (0-14/15-90 days) weighted proportional hazards model of mortality for antibiotic-treated (n = 1280) and non-antibiotic-treated (n = 277) residents; both weights and regressors provide "doubly robust" risk adjustment-for LRI (illness) severity using a prognostic score and for nonrandom receipt of antibiotic treatment using a propensity score.
RESULTS: In both the United States and the Netherlands, 14-day mortality was associated with three factors-LRI severity, water intake at diagnosis, and antibiotic use (not directly by severe dementia)-that accounted for 82% or, sequentially, 39%, 42%, and 1% of the cross-national mortality difference. The LRI Severity Score (based only on at-diagnosis eating dependency, pulse rate, decreased alertness, and breathing difficulty, with adequate discrimination [c ≥ 0.74] and calibration, and cross-indexed to commonly used LRI mortality measures) was related to mortality through 90 days, regardless of treatment. With sufficient water intake at diagnosis, 14-day mortality was unrelated to not receiving antibiotic treatment (adjusted hazard ratio [AHR], 1.20; 95% confidence interval, 0.70-2.04); insufficient water intake was related to increased 14-day mortality with antibiotics (AHR, 1.90; 1.38-2.60) or without (AHR, 7.12; 4.83-10.5). After 14 days, relative mortality worsened for antibiotic-treated residents with insufficient water intake. Inadequate water intake was related to increased eating dependence at onset of the LRI (OR, 4.2; 3.0-5.8).
CONCLUSION: LRI severity, water intake, and antibiotic use explain mortality in both studies and reconcile cross-study Dutch/US 14-day mortality differences. LRI severity, derived at 14 days, is related to mortality through 90 days, regardless of treatment, and is key to risk adjustment. With adequate hydration, the survival benefit from antibiotic use is nonsignificant. Conversely, hydration, even without antibiotic treatment, appears central to curative treatment. In LRI guidelines, treatment, and research, the relative benefits of antibiotics and hydration for curative treatment should be addressed.
Authors:
Kristina L Szafara; Robin L Kruse; David R Mehr; Miel W Ribbe; Jenny T van der Steen
Related Documents :
21502757 - The japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention ve...
20133227 - Comparatively lower postoperative hepatolithiasis risk with hepaticocholedochostomy ver...
21459217 - Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-rela...
21187527 - Morphometric analysis of treatment effects of bone-anchored maxillary protraction in gr...
25148437 - Comparing two methods of thoracoscopic sympathectomy for palmar hyperhidrosis.
12015817 - An international survey of patients with thalassemia major and their views about sustai...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.     Date:  2011-04-22
Journal Detail:
Title:  Journal of the American Medical Directors Association     Volume:  13     ISSN:  1538-9375     ISO Abbreviation:  J Am Med Dir Assoc     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-04-30     Completed Date:  2012-09-05     Revised Date:  2014-09-15    
Medline Journal Info:
Nlm Unique ID:  100893243     Medline TA:  J Am Med Dir Assoc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  376-83     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Aged
Aged, 80 and over
Anti-Bacterial Agents / therapeutic use*
Cohort Studies
Community-Acquired Infections / diagnosis,  drug therapy,  mortality
Drinking / drug effects*,  physiology
Female
Homes for the Aged
Humans
Male
Netherlands
Nursing Homes*
Pneumonia, Bacterial / diagnosis,  drug therapy*,  mortality*
Prognosis
Prospective Studies
Respiratory Tract Infections / diagnosis,  drug therapy,  mortality
Risk Assessment
Severity of Illness Index
Sex Factors
Survival Analysis
Treatment Outcome
United States
Grant Support
ID/Acronym/Agency:
AG00114/AG/NIA NIH HHS; AG18335/AG/NIA NIH HHS; HS08551/HS/AHRQ HHS; T32 AG000114/AG/NIA NIH HHS; T32 AG000114-20/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Are prodromes preictal events? A prospective PDA-based study.
Next Document:  Vision therapy for basic exotropia in adults: 2 case studies.